These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11709418)

  • 41. Hemodynamic characteristics of conscious deoxycorticosterone acetate hypertensive rats.
    Shimamoto H; Iriuchijima J
    Jpn J Physiol; 1987; 37(2):243-54. PubMed ID: 2957535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Microvascular responses to endothelin in deoxycorticosterone acetate-salt hypertensive rats.
    Zhao H; Joshua IG; Porter JP
    Am J Hypertens; 2000 Jul; 13(7):819-26. PubMed ID: 10933575
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Selective antagonism of endothelin ET(A) or ET(B) receptor in renal hemodynamics and function of deoxycorticosterone acetate-salt-induced hypertensive rats.
    Matsumura Y; Taira S; Kitano R; Hashimoto N; Kuro T
    Biol Pharm Bull; 1999 Aug; 22(8):858-62. PubMed ID: 10480326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endothelin receptor function in mesenteric veins from deoxycorticosterone acetate salt-hypertensive rats.
    Johnson RJ; Fink GD; Watts SW; Galligan JJ
    J Hypertens; 2002 Apr; 20(4):665-76. PubMed ID: 11910302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardiac output and the blood pressure increase in deoxycorticosterone acetate-salt hypertension after nicotine infusion.
    Passmore JC; Jimenez AE; Pierce WM
    Clin Exp Hypertens A; 1991; 13(1):83-102. PubMed ID: 2022074
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endothelin ET(B) receptor-mediated action on systemic and renal hemodynamics and urine formation in deoxycorticosterone acetate-salt-induced hypertensive rats.
    Hashimoto N; Kuro T; Fujita K; Azuma S; Matsumura Y
    Biol Pharm Bull; 1998 Aug; 21(8):800-4. PubMed ID: 9743245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vasopressin induces vascular superoxide via endothelin-1 in mineralocorticoid hypertension.
    Li L; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Mar; 41(3 Pt 2):663-8. PubMed ID: 12623976
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vasopressin and sympathetic nervous functions both contribute to development and maintenance of hypertension in DOCA-salt rats.
    Takata Y; Yamashita Y; Takishita S; Fujishima M
    Clin Exp Hypertens A; 1988; 10(2):203-27. PubMed ID: 3370846
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasopressin-induced increase in total peripheral resistance in deoxycorticosterone acetate hypertensive rats is buffered by the baroreceptor reflex.
    Rascher W; Lang RE; Taubitz M; Meffle H; Unger T; Ganten D; Gross F
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():153s-156s. PubMed ID: 7188584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-HT2B-receptor antagonist LY-272015 is antihypertensive in DOCA-salt-hypertensive rats.
    Watts SW; Fink GD
    Am J Physiol; 1999 Mar; 276(3):H944-52. PubMed ID: 10070078
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gender differences in vascular reactivity to endothelin-1 in deoxycorticosterone-salt hypertensive rats.
    Tostes RC; David FL; Carvalho MH; Nigro D; Scivoletto R; Fortes ZB
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S99-101. PubMed ID: 11078348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reduced contractile sensitivity and vasopressin receptor affinity in DOCA-salt hypertension.
    Bockman CS; Jeffries WB; Pettinger WA; Abel PW
    Am J Physiol; 1992 Jun; 262(6 Pt 2):H1752-8. PubMed ID: 1535757
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contribution of vascular and tubular effects of arginine-vasopressin to the development of deoxycorticosterone acetate (DOCA)-salt hypertension in rats.
    Hofbauer KG; Mah SC; Wood JM; Baum HP; Hänni H; Opperman JR; Kraetz J
    J Hypertens Suppl; 1984 Dec; 2(3):S333-5. PubMed ID: 6599676
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac and vascular responses in deoxycorticosterone acetate-salt hypertensive rats.
    Brown L; Ooi SY; Lau K; Sernia C
    Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):263-9. PubMed ID: 10779123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antidiuretic and pressor actions of vasopressin in age-dependent DOCA-salt hypertension.
    Zicha J; Kunes J; Lébl M; Pohlová I; Slaninová J; Jelínek J
    Am J Physiol; 1989 Jan; 256(1 Pt 2):R138-45. PubMed ID: 2912206
    [TBL] [Abstract][Full Text] [Related]  

  • 56. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
    Li L; Watts SW; Banes AK; Galligan JJ; Fink GD; Chen AF
    Hypertension; 2003 Sep; 42(3):316-21. PubMed ID: 12885792
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD; Pollock DM; Clarke N; Fuchs LC
    Am J Physiol; 1998 Jun; 274(6):R1613-8. PubMed ID: 9608015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular hemodynamics and vasopressin blockade in DOCA-salt hypertensive rats.
    Yamamoto J; Yamane Y; Umeda Y; Yoshioka T; Nakai M; Ikeda M
    Hypertension; 1984; 6(3):397-407. PubMed ID: 6735459
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y; Hashimoto N; Taira S; Kuro T; Kitano R; Ohkita M; Opgenorth TJ; Takaoka M
    Hypertension; 1999 Feb; 33(2):759-65. PubMed ID: 10024341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of antihypertensive treatment and N omega-nitro-L-arginine methyl ester on cardiovascular structure in deoxycorticosterone acetate-salt hypertensive rats.
    Li JS; Sventek P; Schiffrin EL
    J Hypertens; 1996 Nov; 14(11):1331-9. PubMed ID: 8934362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.